American Vanguard Corp.

  • Market Cap: Micro Cap
  • Industry: Chemicals & Petrochemicals
  • ISIN: US0303711081
USD
4.31
-0.31 (-6.71%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About American Vanguard Corp. stock-summary
stock-summary
American Vanguard Corp.
Chemicals & Petrochemicals
American Vanguard Corporation operates as a holding company. The Company conducts its business through its subsidiaries, AMVAC Chemical Corporation (AMVAC), GemChem, Inc. (GemChem), 2110 Davie Corporation (DAVIE), Quimica Amvac de Mexico S.A. de C.V. (AMVAC M), AMVAC Mexico Sociedad de Responsabilidad Limitada (AMVAC M Srl), AMVAC de Costa Rica Sociedad de Responsabilidad Limitada (AMVAC CR Srl), AMVAC Switzerland GmbH (AMVAC S), AMVAC do Brasil Representacoes Ltda (AMVAC B), AMVAC C.V. (AMVAC CV), AMVAC Netherlands BV (AMVAC BV), Envance Technologies, LLC (Envance), AMVAC Singapore Pte, Ltd (AMVAC Sgpr) and Huifeng AMVAC Innovation Co. Limited (Hong Kong JV). AMVAC is a specialty chemical manufacturer that develops and markets products for agricultural, commercial and consumer uses. It manufactures and formulates chemicals, such as insecticides, fungicides, herbicides, molluscicides and soil fumigants for crops, turf and ornamental plants, and human and animal health protection.
Company Coordinates stock-summary
Company Details
4695 Macarthur Ct , NEWPORT BEACH CA : 92660-1882
stock-summary
Tel: 1 949 26012001 949 2601200
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 64 Schemes (45.4%)

Foreign Institutions

Held by 73 Foreign Institutions (9.39%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Eric Wintemute
Chairman of the Board, Chief Executive Officer
Dr. John Killmer
Lead Independent Director
Mr. Scott Baskin
Independent Director
Mr. Lawrence Clark
Independent Director
Dr. Debra Edwards
Independent Director
Mr. Morton Erlich
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
129 Million
(Quarterly Results - Jun 2025)
Net Profit:
-1 Million
stock-summary
Industry

Chemicals & Petrochemicals

stock-summary
Market cap

USD 196 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.79

stock-summary
Return on Equity

-31.28%

stock-summary
Price to Book

0.85